Welcome to ExamTopics
ExamTopics Logo
- Expert Verified, Online, Free.
Mail Us[email protected]
Menu
The-Open-Group Discussions
exam questions

Exam OG0-092 All Questions

View all questions & answers for the OG0-092 exam
Go to Exam

Exam OG0-092 topic 1 question 68 discussion

Actual exam question from The Open Group's OG0-092
Question #: 68
Topic #: 1
[All OG0-092 Questions]

Scenario -
You have been appointed as a consultant to the Chief Enterprise Architect of a multinational corporation. The corporation has over 100,000 employees and is organized into 10 divisions with operations in over 60 countries and products sold in over 125 countries. It has major research sites at 8 locations worldwide.
The operations of the corporation are subject to legal and regulatory requirements for each country where they operate. The production of its products have governmental controls that are strictly enforced and compliance is critical. Recently a competitor was heavily fined for violating the regulations in a country where it was conducting a trial for a new product.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners.
The Enterprise Architecture group is a mature organization. They use the TOGAF ADM with extensions required to support the manufacturing practices and laboratory practices of their target markets. Due to the high sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security, regulatory and privacy issues that are relevant.
The Executive Vice President for Clinical Research in the sponsor of the Enterprise Architecture activity. She has stated that the changes to the Enterprise
Architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographic regions.
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on the TOGAF standard, which of the following is the best answer?

  • A. You would document the factors impacting the Implementation and Migration Plan and group the gaps identified in the domain architecture gap analysis results. For each gap, you would identify a proposed solution and classify it as a new development, purchased solution, or based on an existing product. You would group similar solutions together to form work packages, and identify dependencies between the work packages factoring in the clinical trial schedules. Finally, you would regroup the packages into a set of Capability increments scheduled into a series of Transition Architectures.
  • B. You would use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap, you would classify whether the solution is either a new development, purchased solution, or based on an existing product. You would group the similar solutions together to define the work packages. You would then regroup the work packages into a Set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.
  • C. You would group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, you would then regroup the work packages to account for dependencies. You would sequence the work packages into the Capability Increments needed to achieve the Target Architecture. You would schedule the rollout one region at a time. Finally, you would document the progression of the Enterprise Architecture using a state evolution table.
  • D. You would determine the set of Solution Building Blocks required by identifying which need to be developed and which need to be procured. You would eliminate any duplicate building blocks, and then group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. You would then rank the work packages in terms of cost, and select the most cost-effective options for inclusion in a series of Transition Architectures. Finally, you would schedule a sequential roll out of the work packages across the geographic regions.
Show Suggested Answer Hide Answer
Suggested Answer: D 🗳️
by polymorf at Sept. 25, 2020, 1:11 p.m.

Comments

Chosen Answer:
This is a voting comment (?). It is better to Upvote an existing comment if you don't have anything to add.
Switch to a voting comment New
Submit Cancel
aaa111222
Highly Voted 4 years, 1 month ago
I'd go for A "factors impacting the plan" Transition Architectures B doesn't mention those
upvoted 13 times
susridey
3 years, 4 months ago
correct
upvoted 1 times
...
...
polymorf
Highly Voted 4 years, 2 months ago
Answer is B
upvoted 8 times
Dieter11
3 years ago
Not possible, "The work will need to be done in stages and rolled out in geographic regions." Answer B doesn't comply with this requirement
upvoted 1 times
...
...
modsjunk
Most Recent 1 year, 6 months ago
Ans A should better than B: B doesn't talk about transition architecture, and TOGAF recommends to "Using the Consolidated Gaps, Solutions, and Dependencies matrix together with the Implementation Factor Assessment and Deduction matrix, logically group the various activities into work packages A as it is aligned to the steps of phase E. You need to do the Implementation Factor Assessment & Deduction Matrix first to be able to group the work packages into capability increments and finalize the transition architectures.
upvoted 2 times
...
mericov
2 years, 2 months ago
Selected Answer: B
24.2/24.3
upvoted 1 times
...
Sasi2017
2 years, 6 months ago
Definitely not D as CRUD matrix we use in Data architecture
upvoted 3 times
...
vsudhagar
2 years, 10 months ago
Answer A make more sense.
upvoted 2 times
...
jiten1102
3 years, 4 months ago
why not C, its also talk about "rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials" as per
upvoted 3 times
tushmish
2 years, 6 months ago
SBBs are created as part of gap analysis. Consolidated Gaps, Solutions and Dependencies Matrix lists down the solutions against each gap.
upvoted 1 times
...
...
jayecho
4 years, 1 month ago
ANSWER B
upvoted 3 times
...

Get IT Certification

Unlock free, top-quality video courses on ExamTopics with a simple registration. Elevate your learning journey with our expertly curated content. Register now to access a diverse range of educational resources designed for your success. Start learning today with ExamTopics!

Start Learning for free
Community vote distribution
A (35%)
C (25%)
B (20%)
Other
Most Voted
A voting comment increases the vote count for the chosen answer by one.

Upvoting a comment with a selected answer will also increase the vote count towards that answer by one. So if you see a comment that you already agree with, you can upvote it instead of posting a new comment.

SaveCancel